Company profile
Oncologix Tech Inc.
OTC: OCLG · Healthcare · Medical - Diagnostics & Research
#728 of 1,418 Healthcare companies by revenuetop-decile growth
EA Score
——FH —DQ 13GM —SS 62
v0.1 · 25/100 weight · pillars only
↑ revenue growth (YoY), listing tenure · ↓ Altman-Z, disclosure history
Methodology →Revenue TTM
$2.2M
Rev growth YoY (TTM)
-28.3%
Net income (FY)
-$1.3M
Employees
191
as of 2026-08-28
Market cap
$73.7k
as of 2026-08-28
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$3.7M$3.7M2014
Net income-$1.3M-$1.3M2014
Operating income-$571.8k-$571.8k2014
Total assets$2.1M$2.1M2014
Liabilities$2.8M$2.8M2014
Equity-$664.7k-$664.7k2014
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Oncologix Tech Inc.’s revenue?
Oncologix Tech Inc. booked $3.7M in FY2014 revenue, growing 1406% year over year — faster than 97% of Healthcare companies we track, at a -35.7% net margin.
Neighbors
Lafayette →Key facts
CEOMichael A. Kramarz
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersLafayette, LA
ExchangeOTC: OCLG
Employees191
IPO date1995-03-08
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.